FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Remifentanil Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 06/28/2022
»Therapeutic Categories: Analgesia/Addiction

Expand all

Fresenius Kabi USA, LLC (Reverified 12/05/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 1 mg/1 mL (NDC 63323-723-03)	Unavailable	Backordered. Next release October 2024. Check wholesalers for inventory.	Demand increase for the drug
Injection, 1 mg/1 mL (NDC 63323-724-05)	Unavailable	Backordered. Next release not available at this time. Check wholesaler for inventory.	Demand increase for the drug
Injection, 1 mg/1 mL (NDC 63323-725-10)	Unavailable	Backordered. Next release not available at this time; Check wholesalers for inventory.	Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Revised 11/25/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Remifentanil HCl for Injection, Injection, 1 mg per vial (NDC 0143-9391-10)	Unavailable	Additional lots will be available in the February 2025 timeframe. Product will be made available as it is released.	Demand increase for the drug
Remifentanil HCl for Injection, Injection, 2 mg per vial (NDC 0143-9392-10)	Unavailable	Additional lots will be available in the February 2025 timeframe. Product will be made available as it is released.	Demand increase for the drug
Remifentanil HCl for Injection, Injection, 5 mg per vial (NDC 0143-9393-10)	Unavailable	Additional lots will be available in the February 2025 timeframe. Product will be made available as it is released.	Demand increase for the drug

Mylan Institutional, a Viatris Company (Reverified 12/03/2024)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ultiva, Injection, 2 mg (NDC 72078-035-02)	Available
Ultiva, Injection, 5 mg (NDC 67457-198-10)	Unavailable	Next supply in Q4 2024.	Demand increase for the drug
Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)	Unavailable	Next supply in Q4 2024.	Demand increase for the drug